Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Alkylating
  • Benzimidazoles
  • Dacarbazine
  • Melanoma
  • Uveal Neoplasms

abstract

  • clinicaltrials.gov Identifier: NCT01143402.

authors

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4249701

Digital Object Identifier (DOI)

  • 10.1001/jama.2014.6096

PubMed ID

  • 24938562

Additional Document Info

start page

  • 2397

end page

  • 405

volume

  • 311

number

  • 23